Journal of Multiple Sclerosis

Department of Neurology, University of Texas, Dallas, USA

Publications

• Perspective   
  Unlocking the Long-Term Value Proposition: A Comprehensive Analysis of the Cost-Effectiveness of Glatiramer Acetate in the Treatment Landscape of Relapsing-Remitting Multiple Sclerosis from the UK NHS Perspective
  Author(s): Elche Greeds* and Oman Godsy
  
  In the dynamic realm of Multiple Sclerosis (MS) treatment, the spotlight has recently been cast on the long-term effects of Glatiramer Acetate (GA) and interferons-ß (IFNs), particularly within the confines of the UK Multiple Sclerosis Risk Sharing Scheme (RSS). This article embarks on an exhaustive exploration, offering a detailed and comprehensive perspective on the cost-effectiveness of GA for Relapsing-Remitting Multiple Sclerosis (RRMS) from the standpoint of the UK National Health Service (NHS)... View More»
  

  Abstract HTML PDF